Tabula Rasa HealthCare Stock Price, News & Analysis (NASDAQ:TRHC)

$32.25 -2.08 (-6.06 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$34.33
Today's Range$31.64 - $34.34
52-Week Range$11.59 - $39.81
Volume582,097 shs
Average Volume249,872 shs
Market Capitalization$622.75 million
P/E Ratio-129.00
Dividend YieldN/A
Beta3.93

About Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare logoTabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient's acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Debt-to-Equity Ratio0.47%
Current Ratio0.73%
Quick Ratio0.66%

Price-To-Earnings

Trailing P/E Ratio-129
Forward P/E Ratio1,075.00
P/E Growth3.64

Sales & Book Value

Annual Sales$94.06 million
Price / Sales6.12
Cash Flow$0.35 per share
Price / Cash91.42
Book Value$3.48 per share
Price / Book9.27

Profitability

Trailing EPS($0.25)
Net Income$-6,250,000.00
Net Margins-2.27%
Return on Equity-5.58%
Return on Assets-3.49%

Miscellaneous

Employees241
Outstanding Shares17,850,000

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) released its quarterly earnings data on Monday, November, 6th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.02. The firm had revenue of $33.27 million for the quarter, compared to analysts' expectations of $31.76 million. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The firm's quarterly revenue was up 37.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.06 earnings per share. View Tabula Rasa HealthCare's Earnings History.

When will Tabula Rasa HealthCare make its next earnings announcement?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Monday, March, 12th 2018. View Earnings Estimates for Tabula Rasa HealthCare.

Where is Tabula Rasa HealthCare's stock going? Where will Tabula Rasa HealthCare's stock price be in 2018?

9 analysts have issued twelve-month price objectives for Tabula Rasa HealthCare's shares. Their forecasts range from $16.00 to $41.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $29.29 in the next twelve months. View Analyst Ratings for Tabula Rasa HealthCare.

What are Wall Street analysts saying about Tabula Rasa HealthCare stock?

Here are some recent quotes from research analysts about Tabula Rasa HealthCare stock:

  • 1. According to Zacks Investment Research, "Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. " (1/11/2018)
  • 2. Piper Jaffray Companies analysts commented, "Tabula Rasa reported another strong revenue quarter but guided 1Q17 profitability slightly below expectations in order to ramp up operations to meet the needs of new large accounts. We believe this investment will be leveraged over time because it's supporting the growth of higher margin business, and will also gain efficiency over time. We are reiterating OW, and raising PT to $19 from $18." (3/14/2017)
  • 3. Stifel Nicolaus analysts commented, "On March 13, 2017, Tabula Rasa (TRHC) announced strong results for 4Q16 and full year. 2017 guidance for revenue and adjusted-EBITDA was established in and around expectations but fell slightly short of our modeling. Management provided an update of the operations and key customers along with quarterly remarks and an update on new business. We believe TRHC is a company with unique products that will have an interested audience in coming years given unrelenting healthcare trends that are agnostic to political party. TRHC is Buy-rated. Raise target to $19 (from $17) based on combination of price-to-sales and EV-EBITDA multiples." (3/14/2017)

Who are some of Tabula Rasa HealthCare's key competitors?

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:

  • Calvin H. Knowlton Ph.D., Chairman of the Board, Chief Executive Officer, Co-Founder (Age 67)
  • Orsula Voltis Knowlton, President, Co-Founder, Director (Age 49)
  • Brian W. Adams, Chief Financial Officer (Age 36)
  • Samira K. Beckwith, Director (Age 64)
  • Glen R. Bressner, Independent Director (Age 56)
  • Dennis K. Helling, Independent Director (Age 68)
  • Bruce H. Luehrs, Independent Director (Age 63)
  • A. Gordon Tunstall, Independent Director (Age 73)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Who owns Tabula Rasa HealthCare stock?

Tabula Rasa HealthCare's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Hood River Capital Management LLC (4.95%), Ranger Investment Management L.P. (4.35%), BlackRock Inc. (2.38%), Jennison Associates LLC (2.31%), UBS Asset Management Americas Inc. (1.91%) and Peregrine Capital Management LLC (1.82%). Company insiders that own Tabula Rasa HealthCare stock include Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Growth Fund 1Q Lp Originate, Joann M Durham and Orsula V Knowlton. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Who sold Tabula Rasa HealthCare stock? Who is selling Tabula Rasa HealthCare stock?

Tabula Rasa HealthCare's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cadence Capital Management LLC, Lisanti Capital Growth LLC and Rhumbline Advisers. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

Who bought Tabula Rasa HealthCare stock? Who is buying Tabula Rasa HealthCare stock?

Tabula Rasa HealthCare's stock was bought by a variety of institutional investors in the last quarter, including Ranger Investment Management L.P., UBS Asset Management Americas Inc., Peregrine Capital Management LLC, Castleark Management LLC, Hood River Capital Management LLC, Renaissance Technologies LLC, DSC Advisors L.P. and Monashee Investment Management LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Glen R Bressner. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy Tabula Rasa HealthCare stock?

Shares of Tabula Rasa HealthCare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of Tabula Rasa HealthCare stock can currently be purchased for approximately $32.25.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $622.75 million and generates $94.06 million in revenue each year. The company earns $-6,250,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Tabula Rasa HealthCare employs 241 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (TRHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  97 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  187
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tabula Rasa HealthCare (NASDAQ:TRHC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.892.892.833.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $29.29$29.29$28.33$18.75
Price Target Upside: 0.36% upside0.36% upside0.26% upside10.36% upside

Tabula Rasa HealthCare (NASDAQ:TRHC) Consensus Price Target History

Price Target History for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ:TRHC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/4/2018CitigroupInitiated CoverageBuyHighView Rating Details
12/18/2017OppenheimerInitiated CoverageOutperform$35.00LowView Rating Details
12/11/2017William BlairInitiated CoverageOutperform -> OutperformLowView Rating Details
11/7/2017Piper Jaffray CompaniesReiterated RatingOverweight$35.00N/AView Rating Details
11/1/2017First AnalysisInitiated CoverageOverweight$41.00N/AView Rating Details
10/19/2017Wells Fargo & CoBoost Price TargetMarket Perform$21.00 -> $27.00N/AView Rating Details
10/17/2017Robert W. BairdReiterated RatingOutperform$22.00 -> $30.00N/AView Rating Details
8/8/2017Chardan CapitalBoost Price TargetBuy -> Buy$19.50 -> $21.00HighView Rating Details
7/14/2017Stifel NicolausReiterated RatingBuy$16.00LowView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Tabula Rasa HealthCare (NASDAQ:TRHC) Earnings History and Estimates Chart

Earnings by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ TRHC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2018        
11/6/2017Q3 2017$0.06$0.08$31.76 million$33.27 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.06$0.06$27.84 million$29.70 millionViewListenView Earnings Details
5/1/2017Q1 2017$0.06$0.04$26.00 million$27.70 millionViewListenView Earnings Details
3/13/2017Q4 2016$0.11$0.10$25.53 million$27.30 millionViewN/AView Earnings Details
11/9/2016Q316$0.03$0.06$22.35 million$24.17 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Tabula Rasa HealthCare (NASDAQ:TRHC) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20181$0.15$0.15$0.15
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Tabula Rasa HealthCare (NASDAQ:TRHC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Tabula Rasa HealthCare (NASDAQ TRHC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 45.80%
Institutional Ownership Percentage: 41.58%
Insider Trades by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)
Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ TRHC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/7/2018Calvin H KnowltonCEOSell8,000$34.75$278,000.00View SEC Filing  
1/12/2018Brian W AdamsCFOBuy5,391$14.23$76,713.93View SEC Filing  
1/8/2018Calvin H KnowltonCEOSell8,000$32.75$262,000.00View SEC Filing  
12/11/2017Bruce LuehrsDirectorSell269,000$25.85$6,953,650.00View SEC Filing  
12/11/2017Growth Fund 1Q Lp OriginateMajor ShareholderSell684,180$25.85$17,686,053.00View SEC Filing  
12/8/2017Gordon TunstallDirectorSell15,000$25.85$387,750.00View SEC Filing  
12/8/2017Orsula V KnowltonInsiderSell123,000$25.97$3,194,310.00View SEC Filing  
10/18/2017Orsula V KnowltonInsiderSell8,000$26.68$213,440.00View SEC Filing  
9/13/2017Orsula V KnowltonInsiderSell8,000$22.10$176,800.00887,407View SEC Filing  
8/16/2017Calvin H KnowltonCEOSell8,000$17.21$137,680.00918,362View SEC Filing  
7/19/2017Orsula V KnowltonInsiderSell8,000$14.20$113,600.00903,407View SEC Filing  
6/14/2017Orsula V. KnowltonInsiderSell8,000$14.02$112,160.00View SEC Filing  
6/12/2017Gordon TunstallDirectorSell22,759$13.76$313,163.845,565View SEC Filing  
5/18/2017Glen R BressnerDirectorBuy7,500$11.96$89,700.0018,256View SEC Filing  
5/17/2017Orsula V KnowltonInsiderSell8,000$11.94$95,520.00919,407View SEC Filing  
10/4/2016Glen R BressnerDirectorBuy8,500$12.00$102,000.002,793,932View SEC Filing  
10/4/2016Joann M DurhamMajor ShareholderSell4,070$12.00$48,840.0012,886View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tabula Rasa HealthCare (NASDAQ TRHC) News Headlines

Source:
DateHeadline
Tabula Rasa HealthCare CEO Presents at IBC Innovation DayTabula Rasa HealthCare CEO Presents at IBC Innovation Day
finance.yahoo.com - February 22 at 4:55 PM
Tabula Rasa HealthCare (TRHC) Downgraded by BidaskClubTabula Rasa HealthCare (TRHC) Downgraded by BidaskClub
www.americanbankingnews.com - February 21 at 7:42 PM
Tabula Rasa HealthCare Inc (TRHC) Given Average Recommendation of "Buy" by AnalystsTabula Rasa HealthCare Inc (TRHC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - February 20 at 7:44 PM
Tabula Rasa HealthCare Inc (TRHC) Expected to Post Quarterly Sales of $39.06 MillionTabula Rasa HealthCare Inc (TRHC) Expected to Post Quarterly Sales of $39.06 Million
www.americanbankingnews.com - February 17 at 4:30 AM
Tabula Rasa HealthCare Inc (TRHC) Expected to Post Earnings of $0.16 Per ShareTabula Rasa HealthCare Inc (TRHC) Expected to Post Earnings of $0.16 Per Share
www.americanbankingnews.com - February 15 at 7:18 PM
Tabula Rasa HealthCare Inc (TRHC) CEO Calvin H. Knowlton Sells 8,000 SharesTabula Rasa HealthCare Inc (TRHC) CEO Calvin H. Knowlton Sells 8,000 Shares
www.americanbankingnews.com - February 8 at 12:46 AM
Tabula Rasa HealthCare Inc (TRHC) Receives Average Rating of "Buy" from AnalystsTabula Rasa HealthCare Inc (TRHC) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - January 26 at 7:28 PM
Is This IPO With 322% Growth Following In Facebook's Footsteps?Is This IPO With 322% Growth Following In Facebook's Footsteps?
finance.yahoo.com - January 22 at 5:56 PM
Tabula Rasa HealthCare Inc (TRHC) CFO Brian W. Adams Purchases 5,391 SharesTabula Rasa HealthCare Inc (TRHC) CFO Brian W. Adams Purchases 5,391 Shares
www.americanbankingnews.com - January 17 at 9:34 PM
Tabula Rasa HealthCare Inc (TRHC) Expected to Announce Quarterly Sales of $39.06 MillionTabula Rasa HealthCare Inc (TRHC) Expected to Announce Quarterly Sales of $39.06 Million
www.americanbankingnews.com - January 14 at 1:52 AM
Tabula Rasa HealthCare Launches Innovative Medication Therapy Management Services for Behavioral Health Medicaid Programs in Florida and VirginiaTabula Rasa HealthCare Launches Innovative Medication Therapy Management Services for Behavioral Health Medicaid Programs in Florida and Virginia
finance.yahoo.com - January 11 at 4:19 PM
Tabula Rasa HealthCare (TRHC) Upgraded by Zacks Investment Research to Strong-BuyTabula Rasa HealthCare (TRHC) Upgraded by Zacks Investment Research to Strong-Buy
www.americanbankingnews.com - January 11 at 1:46 PM
Tabula Rasa HealthCare Inc (TRHC) CEO Sells $262,000.00 in StockTabula Rasa HealthCare Inc (TRHC) CEO Sells $262,000.00 in Stock
www.americanbankingnews.com - January 9 at 7:16 PM
BRIEF-Tabula Rasa Announces New Contracts With PBMSBRIEF-Tabula Rasa Announces New Contracts With PBMS
www.reuters.com - January 5 at 10:57 AM
Financial Comparison: Tabula Rasa HealthCare (TRHC) & Veeva Systems (VEEV)Financial Comparison: Tabula Rasa HealthCare (TRHC) & Veeva Systems (VEEV)
www.americanbankingnews.com - January 4 at 5:04 PM
Tabula Rasa HealthCare Engaged to Provide Opioid Education and Interventions to Physicians with Patients at High-Risk for Unintentional MisuseTabula Rasa HealthCare Engaged to Provide Opioid Education and Interventions to Physicians with Patients at High-Risk for Unintentional Misuse
finance.yahoo.com - January 4 at 10:40 AM
Tabula Rasa HealthCare Plans for a 30% Increase in Medicare Lives Receiving Medication Therapy Management Services for 2018Tabula Rasa HealthCare Plans for a 30% Increase in Medicare Lives Receiving Medication Therapy Management Services for 2018
finance.yahoo.com - January 4 at 10:40 AM
Tabula Rasa HealthCare (TRHC) Cut to Sell at Zacks Investment ResearchTabula Rasa HealthCare (TRHC) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - January 2 at 2:56 PM
Tabula Rasa HealthCare Inc (TRHC) Receives Average Recommendation of "Buy" from BrokeragesTabula Rasa HealthCare Inc (TRHC) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - January 1 at 7:40 PM
ETFs with exposure to Tabula Rasa Healthcare, Inc. : December 29, 2017ETFs with exposure to Tabula Rasa Healthcare, Inc. : December 29, 2017
finance.yahoo.com - December 29 at 4:10 PM
$39.06 Million in Sales Expected for Tabula Rasa HealthCare Inc (TRHC) This Quarter$39.06 Million in Sales Expected for Tabula Rasa HealthCare Inc (TRHC) This Quarter
www.americanbankingnews.com - December 29 at 2:50 PM
Tabula Rasa Healthcare, Inc. :TRHC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 28, 2017Tabula Rasa Healthcare, Inc. :TRHC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 28, 2017
finance.yahoo.com - December 28 at 1:39 PM
Tabula Rasa HealthCare (TRHC) Upgraded by BidaskClub to BuyTabula Rasa HealthCare (TRHC) Upgraded by BidaskClub to Buy
www.americanbankingnews.com - December 21 at 7:58 PM
Tabula Rasa HealthCare Subsidiary Partners with The Health Plan of San Mateo to deliver Comprehensive Medication Management ServicesTabula Rasa HealthCare Subsidiary Partners with The Health Plan of San Mateo to deliver Comprehensive Medication Management Services
finance.yahoo.com - December 20 at 4:12 PM
Should You Be Concerned About Tabula Rasa Healthcare Inc’s (NASDAQ:TRHC) -110.6% Earnings Decline?Should You Be Concerned About Tabula Rasa Healthcare Inc’s (NASDAQ:TRHC) -110.6% Earnings Decline?
finance.yahoo.com - December 20 at 10:49 AM
Tabula Rasa HealthCare (TRHC) Now Covered by Analysts at OppenheimerTabula Rasa HealthCare (TRHC) Now Covered by Analysts at Oppenheimer
www.americanbankingnews.com - December 18 at 5:35 PM
Tabula Rasa HealthCare Inc (TRHC) Major Shareholder Sells $17,686,053.00 in StockTabula Rasa HealthCare Inc (TRHC) Major Shareholder Sells $17,686,053.00 in Stock
www.americanbankingnews.com - December 12 at 5:40 PM
Tabula Rasa HealthCare Named Best Performing IPO Among Top 50 Digital Health Companies in 2017Tabula Rasa HealthCare Named Best Performing IPO Among Top 50 Digital Health Companies in 2017
finance.yahoo.com - December 12 at 4:27 PM
Is Tabula Rasa Healthcare Inc’s (undefined:TRHC) Balance Sheet Strong Enough To Weather A Storm?Is Tabula Rasa Healthcare Inc’s (undefined:TRHC) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - December 12 at 11:14 AM
Insider Selling: Tabula Rasa HealthCare Inc (TRHC) Director Sells 15,000 Shares of StockInsider Selling: Tabula Rasa HealthCare Inc (TRHC) Director Sells 15,000 Shares of Stock
www.americanbankingnews.com - December 11 at 8:26 PM
Insider Selling: Tabula Rasa HealthCare Inc (TRHC) Insider Sells 123,000 Shares of StockInsider Selling: Tabula Rasa HealthCare Inc (TRHC) Insider Sells 123,000 Shares of Stock
www.americanbankingnews.com - December 11 at 8:26 PM
Tabula Rasa HealthCare Inc (TRHC) Director Sells $6,953,650.00 in StockTabula Rasa HealthCare Inc (TRHC) Director Sells $6,953,650.00 in Stock
www.americanbankingnews.com - December 11 at 8:26 PM
William Blair Initiates Coverage on Tabula Rasa HealthCare (TRHC)William Blair Initiates Coverage on Tabula Rasa HealthCare (TRHC)
www.americanbankingnews.com - December 11 at 7:52 PM
BidaskClub Downgrades Tabula Rasa HealthCare (TRHC) to BuyBidaskClub Downgrades Tabula Rasa HealthCare (TRHC) to Buy
www.americanbankingnews.com - December 10 at 11:36 AM
Tabula Rasa Healthcare Inc. (TRHC) Expected to Post Earnings of $0.16 Per ShareTabula Rasa Healthcare Inc. (TRHC) Expected to Post Earnings of $0.16 Per Share
www.americanbankingnews.com - December 9 at 9:08 PM
Tabula Rasa Healthcare Inc. (TRHC) Given Average Rating of "Buy" by BrokeragesTabula Rasa Healthcare Inc. (TRHC) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 7 at 7:28 PM
Contrasting Veeva Systems (VEEV) & Tabula Rasa Healthcare (TRHC)Contrasting Veeva Systems (VEEV) & Tabula Rasa Healthcare (TRHC)
www.americanbankingnews.com - December 6 at 5:30 PM
BRIEF-Tabula Rasa Healthcare Announces Proposed Offering Of Common StockBRIEF-Tabula Rasa Healthcare Announces Proposed Offering Of Common Stock
www.reuters.com - December 5 at 12:28 PM
Tabula Rasa HealthCare (TRHC) Announces 3M Share OfferingTabula Rasa HealthCare (TRHC) Announces 3M Share Offering
www.streetinsider.com - December 5 at 12:28 PM
Tabula Rasa HealthCare Announces Proposed Offering of Common StockTabula Rasa HealthCare Announces Proposed Offering of Common Stock
finance.yahoo.com - December 4 at 4:12 PM
Financial Analysis: Tabula Rasa Healthcare (TRHC) & Complete Genomics (GNOM)Financial Analysis: Tabula Rasa Healthcare (TRHC) & Complete Genomics (GNOM)
www.americanbankingnews.com - December 2 at 7:24 AM
Comparing NantHealth (NH) & Tabula Rasa Healthcare (TRHC)Comparing NantHealth (NH) & Tabula Rasa Healthcare (TRHC)
www.americanbankingnews.com - November 26 at 4:14 AM
$38.96 Million in Sales Expected for Tabula Rasa Healthcare Inc. (TRHC) This Quarter$38.96 Million in Sales Expected for Tabula Rasa Healthcare Inc. (TRHC) This Quarter
www.americanbankingnews.com - November 23 at 2:46 AM
Equities Analysts Set Expectations for Tabula Rasa Healthcare Inc.s Q3 2018 Earnings (TRHC)Equities Analysts Set Expectations for Tabula Rasa Healthcare Inc.'s Q3 2018 Earnings (TRHC)
www.americanbankingnews.com - November 14 at 10:48 AM
Tabula Rasa Healthcare Inc. (TRHC) Receives Average Rating of "Buy" from BrokeragesTabula Rasa Healthcare Inc. (TRHC) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 12 at 10:38 PM
Zacks Investment Research Lowers Tabula Rasa Healthcare Inc. (TRHC) to HoldZacks Investment Research Lowers Tabula Rasa Healthcare Inc. (TRHC) to Hold
www.americanbankingnews.com - November 10 at 6:58 AM
Sales Growth Keep Tabula Rasa Healthcare (TRHC) a BuySales Growth Keep Tabula Rasa Healthcare (TRHC) a Buy
investorplace.com - November 9 at 7:09 PM
Tabula Rasa HealthCare Announces Third Quarter 2017 Results and Revised Financial OutlookTabula Rasa HealthCare Announces Third Quarter 2017 Results and Revised Financial Outlook
www.nasdaq.com - November 7 at 12:21 PM
Tabula Rasa HealthCares (TRHC) CEO Calvin Knowlton on Q3 2017 Results - Earnings Call TranscriptTabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 12:21 PM
Tabula Rasa HealthCare Announces Third Quarter 2017 ResultsTabula Rasa HealthCare Announces Third Quarter 2017 Results
finance.yahoo.com - November 7 at 12:21 PM

SEC Filings

Tabula Rasa HealthCare (NASDAQ:TRHC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tabula Rasa HealthCare (NASDAQ:TRHC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tabula Rasa HealthCare (NASDAQ TRHC) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.